Ameet Sarpatwari
Ameet Sarpatwari, PhD, JD
Faculty Member of the Center

Ameet Sarpatwari is an Assistant Professor of Medicine at Harvard Medical School and the Assistant Director of the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes.​Dr. Sarpatwari completed his undergraduate studies at the University of Virginia, where he was a Jefferson Scholar. He subsequently studied epidemiology at the University of Cambridge and law at the University of Maryland, where he was a John L. Thomas Leadership Scholar. Dr. Sarpatwari's current work focuses on risk evaluation and mitigation strategies, biosimilars, orphan drug policy, and drug development and pricing. In addition to his work with the Center for Bioethics, he also serves as a Faculty Affiliate with the Department of Health Policy and Management at the Harvard T.H. Chan School of Public Health, the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, and the Behavioral Insights Group at the Harvard Kennedy School. He teaches an annual course on public health law at the Chan School.

Publications View
Variation in Prescription Drug Prices by Retail Pharmacy Type: A National Cross-sectional Study.
Authors: Authors: Luo J, Kulldorff M, Sarpatwari A, Pawar A, Kesselheim AS.
Ann Intern Med
View full abstract on Pubmed
Lung Cancer Survival Gains: Contributions of Academia and Industry.
Authors: Authors: Gyawali B, Bouche G, Pantziarka P, Kesselheim AS, Sarpatwari A.
J Law Med Ethics
View full abstract on Pubmed
Why Are Biosimilars Not Living up to Their Promise in the US?
Authors: Authors: Zhai MZ, Sarpatwari A, Kesselheim AS.
AMA J Ethics
View full abstract on Pubmed
Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions.
Authors: Authors: Dave CV, Patorno E, Franklin JM, Huybrechts K, Sarpatwari A, Kesselheim AS, Bateman BT.
J Gen Intern Med
View full abstract on Pubmed
Reforming the Orphan Drug Act for the 21st Century.
Authors: Authors: Sarpatwari A, Kesselheim AS.
N Engl J Med
View full abstract on Pubmed
Competition and price among brand-name drugs in the same class: A systematic review of the evidence.
Authors: Authors: Sarpatwari A, DiBello J, Zakarian M, Najafzadeh M, Kesselheim AS.
PLoS Med
View full abstract on Pubmed
The Impact Of Price Regulation On The Availability Of New Drugs In Germany.
Authors: Authors: Stern AD, Pietrulla F, Herr A, Kesselheim AS, Sarpatwari A.
Health Aff (Millwood)
View full abstract on Pubmed
Orphan Drug Designation and Exclusivity for "Same Drugs".
Authors: Authors: Hong P, Sarpatwari A, Kesselheim AS.
J Law Med Ethics
View full abstract on Pubmed
Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use.
Authors: Authors: Gopalakrishnan C, Gagne JJ, Sarpatwari A, Dejene SZ, Dutcher SK, Levin R, Franklin JM, Schneeweiss S, Desai RJ.
Clin Pharmacol Ther
View full abstract on Pubmed
Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims.
Authors: Authors: Desai RJ, Sarpatwari A, Dejene S, Khan NF, Lii J, Rogers JR, Dutcher SK, Raofi S, Bohn J, Connolly JG, Fischer MA, Kesselheim AS, Gagne JJ.
PLoS Med
View full abstract on Pubmed

Address: 
Brigham and Women's Hospital
General Medicine-OBC-3030, N2
1620 Tremont St
Boston, MA 02120